| Not Yet Recruiting | Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. NCT06786429 | Eunice Dube | Phase 4 |
| Not Yet Recruiting | TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Re NCT07253220 | Sun Yat-sen University | N/A |
| Recruiting | TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852 | University of Maryland, Baltimore | Phase 1 |
| Not Yet Recruiting | Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain NCT07085715 | Fundació Institut Germans Trias i Pujol | — |
| Recruiting | A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease NCT07168356 | GlaxoSmithKline | Phase 1 |
| Not Yet Recruiting | Scalable Public Health Empowerment, Research, and Education Sites (SPHERES) NCT07126041 | Oxford University Clinical Research Unit Indonesia | N/A |
| Recruiting | A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid NCT06947499 | LG Chem | Phase 2 / Phase 3 |
| Recruiting | Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loa NCT06947356 | Guangzhou 8th People's Hospital | N/A |
| Not Yet Recruiting | Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East NCT06834178 | Vanessa Stadlbauer-Koellner, MD | — |
| Not Yet Recruiting | The Effect of Hot Foot Bath on Sleep Quality and Fatigue NCT06864923 | Uludag University | N/A |
| Completed | Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea NCT06793826 | Sanofi Pasteur, a Sanofi Company | — |
| Recruiting | Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With NCT07079150 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Active Not Recruiting | A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants NCT06537414 | GlaxoSmithKline | Phase 2 |
| Not Yet Recruiting | Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healt NCT06618196 | LG Chem | Phase 2 |
| Recruiting | Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384 NCT06623071 | CerbaXpert | — |
| Active Not Recruiting | Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus I NCT06497504 | GlaxoSmithKline | Phase 2 |
| Recruiting | Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia NCT06586983 | Oslo University Hospital | — |
| Recruiting | Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study) NCT06668727 | Aarhus University Hospital | Phase 1 |
| Not Yet Recruiting | A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Facult NCT06316492 | Assiut University | — |
| Completed | Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in NCT06422767 | GlaxoSmithKline | Phase 1 |
| Not Yet Recruiting | Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy. NCT06421259 | Centre Hospitalier Universitaire de Nice | — |
| Completed | A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites NCT06368466 | bioLytical Laboratories | N/A |
| Completed | Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings NCT06368479 | bioLytical Laboratories | N/A |
| Unknown | UHN Inpatient Hepatitis C & B Screening NCT04620226 | Jordan Feld | Phase 4 |
| Completed | Delivering a Multi-disease Screening Tool to Migrant Populations NCT05868005 | Barcelona Institute for Global Health | N/A |
| Completed | A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects NCT06160895 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |
| Recruiting | National Liver Cancer Screening Trial NCT06084234 | University of Texas Southwestern Medical Center | Phase 4 |
| Completed | A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Pr NCT06058390 | GlaxoSmithKline | Phase 1 |
| Unknown | MENJAGA: Continuous Quality Improvement for Antenatal HIV, Syphilis and Hepatitis B Testing in Indonesia NCT06058286 | Yanri Wijayanti Subronto, MD, PhD, | N/A |
| Completed | The COMBAT HBV Feasibility Trial NCT05705427 | University of North Carolina, Chapel Hill | Phase 4 |
| Recruiting | HepB mAb19 in Individuals With Chronic Hepatitis B Infection NCT05856890 | Rockefeller University | Phase 1 |
| Recruiting | Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients NCT05988879 | Guangzhou 8th People's Hospital | — |
| Unknown | Awareness of Osteoporosis in Patients With Hepatitis B Infection NCT05768737 | Uskudar State Hospital | — |
| Unknown | A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults NCT05952596 | LG Chem | Phase 1 |
| Recruiting | HBsAg Declined Patients Follow-up Study NCT05977283 | Nanfang Hospital, Southern Medical University | — |
| Active Not Recruiting | Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV NCT05551273 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Recruiting | A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. NCT05686759 | GC Biopharma Corp | Phase 3 |
| Unknown | Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Prima NCT05457946 | LG Chem | Phase 2 / Phase 3 |
| Unknown | Multicenter Performance Study of QuadQuik Invitro Diagnostic Device NCT05692505 | Genlantis Diagnostics | — |
| Completed | Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients NCT05957380 | Dong-A ST Co., Ltd. | Phase 4 |
| Unknown | The Efficacy and Safety of Rifaximin Treatment NCT05786859 | Sun Yat-sen University | EARLY_Phase 1 |
| Unknown | Small Volume Blood Testing Validity and Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs) NCT05690607 | Central and North West London NHS Foundation Trust | — |
| Completed | Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Pr NCT05541081 | London School of Hygiene and Tropical Medicine | N/A |
| Terminated | HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers NCT05272735 | Rockefeller University | Phase 4 |
| Recruiting | Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot NCT05390424 | University Hospital, Rouen | N/A |
| Completed | Evaluation of Hepatitis B Virus (HBV) DNA Test As Point of Care Tool NCT05144776 | Kirby Institute | — |
| Unknown | Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict S NCT05394623 | The First Affiliated Hospital with Nanjing Medical University | — |
| Completed | A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years NCT05561673 | GlaxoSmithKline | Phase 1 |
| Withdrawn | Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates NCT05404919 | University of Pennsylvania | Phase 2 |
| Unknown | Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomi NCT05483894 | Samsung Medical Center | Phase 2 |
| Completed | Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes NCT05446532 | Corporacion Parc Tauli | — |
| Unknown | Prevalence of HBV in Pregnancy NCT05442372 | Sohag University | — |
| Completed | Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hep NCT06360484 | National Center for Gastroentestinal and Liver Disease | — |
| Completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers NCT05275465 | Huahui Health | Phase 1 |
| Unknown | Australian Hepatitis and Risk Survey in Prisons NCT05839522 | Kirby Institute | — |
| Active Not Recruiting | Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection NCT05330455 | GlaxoSmithKline | Phase 1 / Phase 2 |
| Recruiting | Liver Cancer Disparities in American Indian and Alaska Native Persons NCT05304234 | University of Washington | Phase 2 |
| Completed | Health and Migration Trajectories of Housekeepers in Bamako NCT05472051 | ANRS, Emerging Infectious Diseases | — |
| Recruiting | Real World Assessment of People Living With Chronic Hepatitis B in Australia NCT04914611 | Kirby Institute | — |
| Completed | Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Admini NCT05127187 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Completed | Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone NCT04710641 | Mina Alpha Limited | Phase 2 |
| Withdrawn | Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays NCT04289428 | Kirby Institute | — |
| Unknown | HBV Reactivation in Anti CD20 Treatment NCT05768061 | HaEmek Medical Center, Israel | — |
| Recruiting | Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Particip NCT04954859 | GlaxoSmithKline | Phase 2 |
| Unknown | Prevention of HCC Using Mobile Phone Applications NCT05094869 | Beijing Friendship Hospital | — |
| Unknown | Prospective Cohort Study on Prognosis of Patients With Hepatitis B/C NCT05102838 | Sun Yat-sen University | — |
| Unknown | Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis NCT05086536 | Beijing Friendship Hospital | — |
| Unknown | Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospit NCT04959643 | University Hospital, Montpellier | — |
| Completed | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine NCT06147895 | CHA Vaccine Institute Co., Ltd. | Phase 1 |
| Completed | Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment NCT04971928 | GlaxoSmithKline | Phase 1 |
| Recruiting | The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort NCT04970836 | National Taiwan University Hospital | N/A |
| Active Not Recruiting | ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk NCT05064553 | Exact Sciences Corporation | — |
| Completed | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects NCT04906109 | Dong-A ST Co., Ltd. | Phase 1 |
| Completed | Cameroon HepB Birth Dose Feasibility Pilot NCT04893616 | Clinton Health Access Initiative Inc. | N/A |
| Completed | Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets NCT04868981 | Fujian Cosunter Pharmaceutical Co. Ltd | Phase 1 |
| Active Not Recruiting | Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) NCT04863703 | Hannover Medical School | — |
| Completed | A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatiti NCT04585789 | Janssen Research & Development, LLC | Phase 2 |
| Completed | Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening NCT04659005 | Chinese University of Hong Kong | N/A |
| Completed | Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) NCT04676724 | GlaxoSmithKline | Phase 2 |
| Completed | Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. NCT04114890 | University of Oxford | Phase 2 |
| Completed | First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV NCT04778904 | Barinthus Biotherapeutics | Phase 1 / Phase 2 |
| Completed | B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B NCT04193189 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Active Not Recruiting | Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population NCT06379334 | Peking Union Medical College Hospital | — |
| Unknown | Combi-elastography Assessment of Chronic Liver Disease Multi-center Study NCT04625166 | Chinese PLA General Hospital | — |
| Completed | Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects NCT04783753 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Completed | Hepatitis B Virus Reactivation in COVID-19 NCT07154212 | University Medical Centre Ljubljana | — |
| Withdrawn | Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal NCT03829735 | Institut Pasteur | N/A |
| Completed | Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunizatio NCT04029454 | Institut Pasteur | N/A |
| Completed | A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B NCT04544956 | GlaxoSmithKline | Phase 2 |
| Recruiting | Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis NCT04588077 | Mercy Medical Center | Phase 4 |
| Completed | A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013) NCT04490499 | Merck Sharp & Dohme LLC | Phase 3 |
| Unknown | Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets NCT04499443 | Fujian Cosunter Pharmaceutical Co. Ltd | Phase 1 |
| Completed | A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) NCT04449029 | GlaxoSmithKline | Phase 2 |
| Completed | Assessing the Reliability of Self-Reported Hepatitis B Vaccination Status in Outpatients: Evaluation of Indivi NCT06998992 | Centre Hospitalier de Saint-Denis | — |
| Unknown | Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Mo NCT04431375 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B NCT04568265 | Ascentage Pharma Group Inc. | Phase 2 |
| Unknown | Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response NCT04326803 | Pontificia Universidad Catolica de Chile | Phase 4 |
| Unknown | Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets NCT04386915 | Fujian Cosunter Pharmaceutical Co. Ltd | Phase 1 |
| Recruiting | Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure NCT04310787 | Third Affiliated Hospital, Sun Yat-Sen University | — |
| Completed | Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects NCT04309526 | Nucorion Pharmaceuticals, Inc. | Phase 1 |
| Completed | Healthy Planet Hepatitis B NCT04503993 | University of California, Davis | N/A |
| Recruiting | Liver Disease and Other Systemic Diseases NCT04525833 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | — |
| Completed | Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children NCT04188223 | PT Bio Farma | Phase 1 |
| Completed | Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients NCT04199715 | Baylor Research Institute | Phase 1 |
| Unknown | RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF NCT04195282 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis NCT03957629 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants NCT04073459 | LG Chem | Phase 2 |
| Completed | Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders NCT05791851 | University of Maryland, Baltimore | — |
| Completed | Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening NCT04109625 | University Hospital, Grenoble | N/A |
| Terminated | Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepat NCT04059198 | F-star Therapeutics, Inc. | Phase 2 |
| Unknown | A Phase IV Study to Assess the Safety of EupentaTM Inj NCT04056728 | LG Chem | Phase 4 |
| Completed | Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC NCT03897946 | University of North Carolina, Chapel Hill | Phase 4 |
| Recruiting | Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B NCT03933384 | Taichung Veterans General Hospital | Phase 4 |
| Completed | Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients NCT04083157 | The University of Hong Kong | Phase 2 / Phase 3 |
| Completed | A Study in Healthy Volunteers NCT03596697 | Hepion Pharmaceuticals, Inc. | Phase 1 |
| Completed | Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) NCT04075201 | Sinovac Biotech Co., Ltd | Phase 1 |
| Terminated | Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Inf NCT04023721 | F-star Therapeutics, Inc. | Phase 2 |
| Unknown | Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate NCT04202536 | IlDong Pharmaceutical Co Ltd | Phase 4 |
| Unknown | Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer NCT05181826 | Helio Genomics | — |
| Completed | B/F/TAF Switch Study for HIV-HBV Coinfection NCT03797014 | University of Maryland, Baltimore | Phase 4 |
| Terminated | Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients NCT03932513 | F-star Therapeutics, Inc. | Phase 2 |
| Completed | HBV/HCV/HIV in Belgian Prisons NCT04366492 | Hasselt University | N/A |
| Unknown | TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR) NCT03798119 | Kaohsiung Medical University Chung-Ho Memorial Hospital | Phase 4 |
| Recruiting | Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of NCT03825458 | Hospices Civils de Lyon | — |
| Recruiting | Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF NCT03920618 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients NCT03801798 | Green Cross Corporation | Phase 2 |
| Completed | First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection NCT04297917 | Barinthus Biotherapeutics | Phase 1 |
| Unknown | Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibro NCT03920605 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver NCT03919565 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Fail NCT03640728 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment NCT03577938 | Beijing 302 Hospital | N/A |
| Unknown | Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated NCT04196998 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | Epidemiology of Hepatitis B, C and Delta in Reunion Island NCT03362866 | Centre Hospitalier Universitaire de la Réunion | — |
| Unknown | To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr NCT03771677 | Sun Yat-sen University | N/A |
| Completed | Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population NCT03702998 | Chinese University of Hong Kong | — |
| Completed | Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections NCT04363411 | Hasselt University | N/A |
| Terminated | An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection NCT03692897 | Target PharmaSolutions, Inc. | — |
| Recruiting | hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b NCT03826433 | Sclnow Biotechnology Co., Ltd. | Phase 1 |
| Completed | Arresting Vertical Transmission of Hepatitis B Virus NCT03567382 | University of North Carolina, Chapel Hill | Phase 4 |
| Unknown | Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty NCT03604016 | IlDong Pharmaceutical Co Ltd | Phase 4 |
| Unknown | Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Anti NCT03566030 | Yonsei University | — |
| Unknown | Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001 NCT03625934 | Viravaxx AG | Phase 2 |
| Active Not Recruiting | Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection NCT03343431 | Institut de Recherche pour le Developpement | Phase 3 |
| Completed | Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis NCT03620474 | Kiminori Kimura, MD | Phase 1 / Phase 2 |
| Terminated | Mild Hypothermia and Acute Kidney Injury in Liver Transplantation NCT03534141 | University of California, San Francisco | N/A |
| Completed | Evaluation of an Infant Immunization Encouragement Program in Nigeria NCT03870061 | GiveWell | N/A |
| Unknown | Stop Hep B @ Birth NCT04998838 | Myanmar Liver Foundation | N/A |
| Completed | Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children NCT04294433 | Laval University | Phase 4 |
| Completed | Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus NCT02995005 | Johns Hopkins Bloomberg School of Public Health | Phase 1 / Phase 2 |
| Unknown | Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV) NCT03680183 | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | — |
| Completed | Crowdsourcing to Promote HBV and HCV Testing in China NCT03482388 | University of North Carolina, Chapel Hill | N/A |
| Completed | Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines NCT03410953 | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | Phase 4 |
| Completed | Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant NCT03511794 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) NCT03365947 | Arrowhead Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine NCT03931239 | Vabiotech | N/A |
| Completed | An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus NCT03361956 | Janssen Sciences Ireland UC | Phase 2 |
| Completed | Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection NCT03312023 | University of Maryland, Baltimore | Phase 2 |
| Unknown | A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers NCT03568578 | Peking University First Hospital | N/A |
| Completed | A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Ch NCT03426618 | Bristol-Myers Squibb | — |
| Unknown | Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan NCT03341195 | Aga Khan University | N/A |
| Completed | Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHe NCT05002907 | Centre Hospitalier de Cayenne | — |
| Completed | Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar NCT03579576 | Right to Care | — |
| Active Not Recruiting | Entecavir to TAF Switch NCT03489239 | Thomas Jefferson University | Phase 3 |
| Completed | Hepatitis B Vaccine for Non-responders NCT03415672 | Maastricht University Medical Center | Phase 2 |
| Completed | A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in He NCT03285620 | Alios Biopharma Inc. | Phase 1 |
| Unknown | Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg NCT03396458 | Hasselt University | — |
| Unknown | Immunogenicity of the Hepatitis B Vaccine NCT04540653 | Universidade Federal de Goias | Phase 4 |
| Completed | Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria NCT04264312 | Wu Jiang | — |
| Completed | A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults NCT03208101 | LG Chem | Phase 1 |
| Unknown | Immunologic Response of Hepatitis B Vaccine NCT03219203 | Chiang Mai University | Phase 4 |
| Unknown | Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD NCT03973502 | National Taiwan University Hospital | N/A |
| Completed | Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infectio NCT03248622 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Hepatitis B Virus Prevalence and Risk Factors in Belgium NCT03425513 | Hasselt University | — |
| Unknown | Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France NCT02959684 | University Paris 7 - Denis Diderot | — |
| Completed | Pilot Study of HIV and Hepatitis B and C Screening in Surgery NCT03088995 | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | — |
| Unknown | To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotid NCT03123653 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of NCT03084250 | Shanghai Nanhui Nanhua Hospital | Phase 4 |
| Completed | Characterisation of Human B Cell Maturation in Response to Vaccination NCT03535779 | Imperial College London | — |
| Completed | Immunity to Hepatitis B Vaccine NCT03083158 | University of British Columbia | Phase 4 |
| Completed | Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With NCT02981602 | GlaxoSmithKline | Phase 2 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in C NCT03020745 | GlaxoSmithKline | Phase 2 |
| Terminated | Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir NCT03032536 | Alios Biopharma Inc. | Phase 1 |
| Completed | Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT NCT04947475 | Yale University | N/A |
| Completed | Entecavir for Decompensated HBV Cirrhosis NCT03345498 | Sanjay Gandhi Postgraduate Institute of Medical Sciences | — |
| Unknown | TAF Switch Study in Hepatitis B Monoinfection NCT02957994 | Asian Pacific Liver Center at Coalition of Inclusive Medicine | Phase 4 |
| Completed | Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patient NCT02791386 | Bristol-Myers Squibb | — |
| Completed | ID HBV Vaccination With Imiquimod in OBI NCT03307902 | The University of Hong Kong | Phase 2 / Phase 3 |
| Unknown | French HIV-HBV Cohort NCT02889094 | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | — |
| Completed | Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers NCT02853929 | GlaxoSmithKline | Phase 4 |
| Completed | A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a NCT02858440 | GlaxoSmithKline | Phase 3 |
| Unknown | Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome NCT03027258 | University of Nevada, Las Vegas | N/A |
| Completed | A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Chal NCT02798952 | GlaxoSmithKline | Phase 4 |
| Completed | A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada NCT02985450 | University of Calgary | — |
| Completed | DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infect NCT02817451 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV NCT02909023 | Hospices Civils de Lyon | — |
| Terminated | A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) NCT02826018 | Alnylam Pharmaceuticals | Phase 1 |
| Completed | The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Pati NCT03546530 | The First Hospital of Jilin University | N/A |
| Terminated | A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB) NCT02797522 | Arrowhead Pharmaceuticals | Phase 1 |
| Unknown | Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies? NCT02799316 | Sherief Abd-Elsalam | N/A |
| Not Yet Recruiting | Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma NCT02779465 | Third Affiliated Hospital, Sun Yat-Sen University | Phase 4 |
| Completed | Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy NCT03181113 | Xiamen Amoytop Biotech Co., Ltd. | — |
| Completed | A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With C NCT02751996 | F-star Therapeutics, Inc. | Phase 2 |
| Completed | Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study NCT02766933 | Mayo Clinic | — |
| Completed | Dynamic Liver Tests in Liver Disease NCT02782247 | Queen Mary University of London | — |
| Completed | Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Prev NCT02759354 | MCM Vaccines B.V. | Phase 3 |
| Completed | Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID NCT02186977 | Novosanis NV | Phase 1 |
| Terminated | Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatiti NCT02738008 | Arrowhead Pharmaceuticals | Phase 2 |
| Unknown | Chronic Hepatitis B and C Recall Northern Holland NCT02687061 | Stichting MDL Holland-Noord | — |
| Completed | Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Va NCT02697474 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda NCT04177485 | Centers for Disease Control and Prevention | N/A |
| Unknown | Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Pa NCT02849132 | Beijing Friendship Hospital | Phase 4 |
| Completed | The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening NCT04240678 | University of California, Davis | N/A |
| Completed | First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Sub NCT02647281 | GlaxoSmithKline | Phase 1 |
| Completed | Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepat NCT02402699 | Bristol-Myers Squibb | — |
| Terminated | Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) NCT02577029 | Arrowhead Pharmaceuticals | Phase 2 |
| Unknown | Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides NCT02644538 | The Second Affiliated Hospital of Chongqing Medical University | Phase 4 |
| Completed | Pharmacokinetics of Two Formulations of Entecavir NCT02850848 | Yung Shin Pharm. Ind. Co., Ltd. | Phase 4 |
| Completed | A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™ NCT04179786 | VBI Vaccines Inc. | Phase 4 |
| Completed | Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent NCT02610348 | Sanofi Pasteur, a Sanofi Company | N/A |
| Terminated | A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B V NCT02604212 | Arrowhead Pharmaceuticals | Phase 2 |
| Completed | A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recom NCT02584543 | Xiamen Innovax Biotech Co., Ltd | Phase 4 |
| Completed | Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders NCT02540538 | Maastricht University Medical Center | Phase 1 |
| Terminated | A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B V NCT02604199 | Arrowhead Pharmaceuticals | Phase 2 |
| Withdrawn | Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively NCT02605538 | Karolinska University Hospital | N/A |
| Completed | A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders NCT02434848 | Sheffield Teaching Hospitals NHS Foundation Trust | Phase 2 / Phase 3 |
| Terminated | Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection NCT02479880 | Gilead Sciences | Phase 4 |
| Completed | Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) NCT02749864 | Instituto de Investigación Marqués de Valdecilla | — |
| Completed | Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B NCT02496897 | Altimmune, Inc. | Phase 1 |
| Unknown | Tenofovir to Prevent HBV Reactivation NCT02186574 | University Health Network, Toronto | Phase 3 |
| Unknown | Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates NCT02764671 | Shenzhen Kangtai Biological Products Co., LTD | Phase 4 |
| Withdrawn | Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 NCT02135666 | GlaxoSmithKline | Phase 4 |
| Completed | Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients In NCT02003703 | Universidad de Valparaiso | Phase 3 |
| Completed | Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 NCT02428491 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection NCT02511743 | Peking University First Hospital | — |
| Unknown | Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence NCT02417207 | Third Affiliated Hospital, Sun Yat-Sen University | Phase 4 |
| Completed | Hepatitis B Birth Dose for Newborns NCT04870021 | Quaid-e-Azam University | Phase 4 |
| Unknown | Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Week NCT02257645 | LG Life Sciences | — |
| Unknown | To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic He NCT02982837 | King Abdullah International Medical Research Center | Phase 4 |
| Completed | Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts NCT02732054 | Chiang Mai University | Phase 4 |
| Completed | Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects NCT02431312 | Inovio Pharmaceuticals | Phase 1 |
| Completed | Hepatitis B Vaccination in HIV-infected Adults NCT02713620 | Chiang Mai University | Phase 4 |
| Active Not Recruiting | Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa NCT02344498 | Oslo University Hospital | — |
| Completed | Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemod NCT03149874 | Benha University | N/A |
| Terminated | Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B NCT02288208 | TetraLogic Pharmaceuticals | Phase 1 |
| Completed | Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania NCT04325542 | Medical Mission Institute, Germany | N/A |
| Completed | This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 NCT02324218 | GlaxoSmithKline | — |
| Completed | Follow-up of HBsAg Inactive Carriers Study NCT02247752 | Centre Hospitalier Régional d'Orléans | N/A |
| Completed | A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV NCT02421666 | Temple University | N/A |
| Completed | Hepatitis B Booster Study in Adolescence NCT02169674 | University of British Columbia | Phase 4 |
| Completed | Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study NCT02548325 | Corporacion Parc Tauli | — |
| Terminated | Clinical Performance Evaluation of DxN HBV Assay NCT03123159 | Beckman Coulter, Inc. | — |
| Completed | Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis NCT02445703 | Sinovac Biotech Co., Ltd | Phase 4 |
| Completed | A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vac NCT02032160 | University of Surrey | N/A |
| Completed | Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B® NCT04209400 | VBI Vaccines Inc. | Phase 3 |
| Completed | Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 a NCT02096263 | GlaxoSmithKline | Phase 3 |
| Completed | HBV-HIV Coinfection Research Network NCT01924455 | Virginia Commonwealth University | — |
| Completed | The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults NCT02057263 | Massachusetts General Hospital | Phase 1 |
| Unknown | Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity NCT02148562 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed NCT02094833 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Heal NCT02203357 | Peking University | Phase 4 |
| Completed | Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers NCT02055365 | Rockefeller University | N/A |
| Completed | This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the I NCT02052661 | GlaxoSmithKline | Phase 4 |
| Completed | Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccin NCT01948193 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Patient-Centered Care and Asian Americans NCT02139722 | University of California, San Francisco | N/A |
| Completed | Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound NCT02044523 | Centre hospitalier de l'Université de Montréal (CHUM) | — |
| Completed | Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years NCT02012998 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Unknown | Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis NCT01998620 | Zhejiang Hisun Pharmaceutical Co. Ltd. | Phase 4 |
| Completed | A Study of the Immune Response to Heplisav in Healthy Older Adults NCT01999699 | Dynavax Technologies Corporation | Phase 1 |
| Completed | Optimizing HBV Management During Anti-CD20 Antibodies NCT03155984 | The University of Hong Kong | — |
| Unknown | RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure NCT02331745 | Beijing 302 Hospital | Phase 4 |
| Completed | Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa NCT01983540 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve NCT01878435 | Johns Hopkins Bloomberg School of Public Health | N/A |
| Completed | Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases NCT01988753 | Baylor College of Medicine | — |
| Completed | A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject NCT01917357 | Crucell Holland BV | Phase 3 |
| Withdrawn | A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alp NCT01727271 | Merck Sharp & Dohme LLC | Phase 4 |
| Unknown | Immune Response in Patients With Hepatitis B and C Infection NCT02275221 | Mid and South Essex NHS Foundation Trust | — |
| Completed | Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters NCT01962155 | Peking University First Hospital | — |
| Completed | Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With NCT01847430 | GlaxoSmithKline | Phase 4 |
| Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurolo NCT01931644 | Sanguine Biosciences | — |
| Completed | Hepatitis B Vaccination in Infants NCT01896596 | Public Health England | Phase 4 |
| Recruiting | Blood Collection Biorepository for Liver Disease Research NCT03025074 | State University of New York at Buffalo | — |
| Completed | Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy NCT01970254 | M.D. Anderson Cancer Center | — |
| Completed | Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans NCT02760537 | Thomas Jefferson University | N/A |
| Active Not Recruiting | HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B NCT01796457 | University of Pennsylvania | — |
| Completed | New Methods to Measure the Immune Response to Hepatitis B Vaccine NCT01821547 | University of Oxford | Phase 4 |
| Completed | Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface An NCT01777295 | GlaxoSmithKline | Phase 2 |
| Completed | Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests NCT01790633 | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | N/A |
| Unknown | Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With L NCT01765231 | Peking University | Phase 4 |
| Unknown | Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemothe NCT01768195 | Peking University | Phase 4 |
| Completed | A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant NCT01856413 | Biotest | Phase 3 |
| Completed | Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepa NCT01369212 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Terminated | Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment NCT01715987 | New Discovery LLC | — |
| Completed | Thousand Asian American Study NCT02596438 | University of California, Davis | — |
| Completed | Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Ci NCT01884415 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 3 |
| Completed | Study for Consolidation Period of Chronic Hepatitis B NCT01732354 | Tainan Municipal Hospital | — |
| Completed | Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection NCT01368497 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Improving Blood Safety and HIV Testing in Brazil NCT01681420 | Vitalant Research Institute | N/A |
| Completed | Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Inje NCT01606163 | Green Cross Corporation | Phase 1 |
| Completed | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Typ NCT01627340 | GlaxoSmithKline | Phase 4 |
| Unknown | Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss NCT01599130 | Sun Yat-sen University | N/A |